Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy have?
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy has 629 citations in the OpenAlex counts ScholarIQ stores.
When was Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy published?
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy has 2018 year in the ScholarIQ index.
What is the open-access status of Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy?
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy has bronze oa status in the ScholarIQ index.
What is the DOI of Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy?
The DOI for Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy is on the source record.
What is the PMID of Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy?
The PMID for Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy is on the source record.
What is the OpenAlex record for Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy?
The OpenAlex for Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy is on the source record.